Granules India Limited | GRANULES | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 498 | 1,156 | 890 | 2,839 | 2,710 |
Short-term investment |
| 0 | 0 | 0 | 0 | 0 |
Accounts receivables |
| 4,177 | 6,171 | 6,735 | 7,352 | 7,654 |
Inventories |
| 2,761 | 2,799 | 3,842 | 4,384 | 7,822 |
Deferred income taxes |
| 0 | 0 | 0 | 0 | 0 |
Other current assets |
| 915 | 1,406 | 1,354 | 2,443 | 1,784 |
Total current assets |
| 8,351 | 11,532 | 12,822 | 17,018 | 19,970 |
Gross property plant... |
| 5,687 | 7,008 | 7,476 | 9,888 | 10,712 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 5,687 | 7,008 | 7,476 | 9,888 | 10,712 |
Work in Progress |
| 2,605 | 2,901 | 3,235 | 1,481 | 1,848 |
Miscellaneous Investment |
| 1,082 | 1,696 | 2,273 | 360 | 321 |
Deferred income taxes |
| 24 | 74 | 59 | 58 | 65 |
Intangible assets |
| 756 | 3,004 | 3,691 | 3,613 | 3,151 |
Goodwill |
| 0 | 0 | 0 | 0 | 0 |
Other long-term assets |
| 259 | 224 | 271 | 597 | 1,068 |
Total non-current assets |
| 10,414 | 14,907 | 17,006 | 15,997 | 17,164 |
Total assets |
| 18,764 | 26,439 | 29,828 | 33,015 | 37,135 |
Short-term debt |
| 4,738 | 5,251 | 4,542 | 3,717 | 4,093 |
Accounts Payable... |
| 2,160 | 2,522 | 3,235 | 4,300 | 5,410 |
Provisions |
| 0 | 27 | 43 | 60 | 68 |
Taxes Payable |
| 0 | 60 | 9 | 57 | 152 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 0 | 0 |
Other current liabilities |
| 950 | 587 | 1,136 | 1,532 | 2,008 |
Total current liabilities |
| 7,848 | 8,446 | 8,965 | 9,665 | 11,731 |
Long-term debt |
| 1,242 | 4,331 | 4,788 | 4,215 | 3,411 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 565 | 543 | 655 | 482 | 11 |
Provisions |
| 0 | 77 | 126 | 215 | 248 |
Capital Leases |
| 0 | 0 | 0 | 0 | 0 |
Other longterm liabilities |
| 72 | 0 | 0 | 0 | 0 |
Total non-current liabilities |
| 1,880 | 4,951 | 5,569 | 4,912 | 3,671 |
Total liabilities |
| 9,728 | 13,397 | 14,533 | 14,578 | 15,402 |
Share Capital |
| 229 | 254 | 254 | 254 | 248 |
Share premium |
| 0 | 0 | 0 | 0 | 0 |
Retained earnings |
| 8,807 | 12,788 | 15,040 | 18,183 | 21,485 |
Accumulated other equity |
| 0 | 0 | 0 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 0 | 0 | 0 | 0 | 0 |
Total Equity |
| 9,036 | 13,042 | 15,295 | 18,437 | 21,733 |
Total Liabilities and Equity |
| 18,764 | 26,439 | 29,828 | 33,015 | 37,135 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |